NM_015225.3:c.3011C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015225.3(PRUNE2):​c.3011C>T​(p.Thr1004Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.566 in 1,612,692 control chromosomes in the GnomAD database, including 264,258 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 20350 hom., cov: 31)
Exomes 𝑓: 0.57 ( 243908 hom. )

Consequence

PRUNE2
NM_015225.3 missense

Scores

1
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.258

Publications

23 publications found
Variant links:
Genes affected
PRUNE2 (HGNC:25209): (prune homolog 2 with BCH domain) The protein encoded by this gene belongs to the B-cell CLL/lymphoma 2 and adenovirus E1B 19 kDa interacting family, whose members play roles in many cellular processes including apotosis, cell transformation, and synaptic function. Several functions for this protein have been demonstrated including suppression of Ras homolog family member A activity, which results in reduced stress fiber formation and suppression of oncogenic cellular transformation. A high molecular weight isoform of this protein has also been shown to colocalize with Adaptor protein complex 2, beta-Adaptin and endodermal markers, suggesting an involvement in post-endocytic trafficking. In prostate cancer cells, this gene acts as a tumor suppressor and its expression is regulated by prostate cancer antigen 3, a non-protein coding gene on the opposite DNA strand in an intron of this gene. Prostate cancer antigen 3 regulates levels of this gene through formation of a double-stranded RNA that undergoes adenosine deaminase actin on RNA-dependent adenosine-to-inosine RNA editing. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
PCA3 (HGNC:8637): (prostate cancer associated 3) This gene produces a spliced, long non-coding RNA that is highly overexpressed in most types of prostate cancer cells and is used as a specific biomarker for this type of cancer. This gene is embedded in an intronic region of the prune2 gene on the opposite DNA strand. The transcript regulates prune2 levels through formation of a double-stranded RNA that undergoes adenosine deaminase acting on RNA-dependent adenosine-to-inosine RNA editing. In prostate cancer derived cells, overexpression of PCA induced downregulation of prune2, leading to decreased cell proliferation. Conversely, silencing in prostate cancer cells resulted in increased proliferation. Regulation of this gene appears to be sensitive to androgen-receptor activation, a molecular signature of prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0055432E-5).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.622 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015225.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRUNE2
NM_015225.3
MANE Select
c.3011C>Tp.Thr1004Met
missense
Exon 8 of 19NP_056040.2
PRUNE2
NM_001308048.2
c.3011C>Tp.Thr1004Met
missense
Exon 8 of 18NP_001294977.1
PRUNE2
NM_001308047.2
c.3011C>Tp.Thr1004Met
missense
Exon 8 of 18NP_001294976.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRUNE2
ENST00000376718.8
TSL:5 MANE Select
c.3011C>Tp.Thr1004Met
missense
Exon 8 of 19ENSP00000365908.3
PRUNE2
ENST00000443509.6
TSL:5
c.3011C>Tp.Thr1004Met
missense
Exon 8 of 18ENSP00000393843.3
PRUNE2
ENST00000428286.5
TSL:5
c.1934C>Tp.Thr645Met
missense
Exon 8 of 19ENSP00000397425.1

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
74880
AN:
151856
Hom.:
20352
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.260
Gnomad AMI
AF:
0.400
Gnomad AMR
AF:
0.634
Gnomad ASJ
AF:
0.706
Gnomad EAS
AF:
0.369
Gnomad SAS
AF:
0.529
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.697
Gnomad NFE
AF:
0.593
Gnomad OTH
AF:
0.574
GnomAD2 exomes
AF:
0.562
AC:
139824
AN:
248656
AF XY:
0.567
show subpopulations
Gnomad AFR exome
AF:
0.250
Gnomad AMR exome
AF:
0.693
Gnomad ASJ exome
AF:
0.697
Gnomad EAS exome
AF:
0.370
Gnomad FIN exome
AF:
0.513
Gnomad NFE exome
AF:
0.599
Gnomad OTH exome
AF:
0.598
GnomAD4 exome
AF:
0.573
AC:
837139
AN:
1460718
Hom.:
243908
Cov.:
56
AF XY:
0.574
AC XY:
417060
AN XY:
726722
show subpopulations
African (AFR)
AF:
0.247
AC:
8274
AN:
33466
American (AMR)
AF:
0.682
AC:
30507
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.695
AC:
18165
AN:
26128
East Asian (EAS)
AF:
0.379
AC:
15031
AN:
39696
South Asian (SAS)
AF:
0.539
AC:
46445
AN:
86242
European-Finnish (FIN)
AF:
0.515
AC:
27518
AN:
53400
Middle Eastern (MID)
AF:
0.708
AC:
4084
AN:
5768
European-Non Finnish (NFE)
AF:
0.588
AC:
652887
AN:
1110952
Other (OTH)
AF:
0.567
AC:
34228
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
19841
39682
59522
79363
99204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17754
35508
53262
71016
88770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.493
AC:
74893
AN:
151974
Hom.:
20350
Cov.:
31
AF XY:
0.493
AC XY:
36571
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.260
AC:
10780
AN:
41456
American (AMR)
AF:
0.633
AC:
9669
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
2451
AN:
3472
East Asian (EAS)
AF:
0.369
AC:
1907
AN:
5170
South Asian (SAS)
AF:
0.531
AC:
2556
AN:
4810
European-Finnish (FIN)
AF:
0.518
AC:
5447
AN:
10524
Middle Eastern (MID)
AF:
0.692
AC:
202
AN:
292
European-Non Finnish (NFE)
AF:
0.593
AC:
40309
AN:
67952
Other (OTH)
AF:
0.573
AC:
1207
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1786
3571
5357
7142
8928
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.568
Hom.:
104359
Bravo
AF:
0.490
ESP6500AA
AF:
0.272
AC:
854
ESP6500EA
AF:
0.605
AC:
4335
ExAC
AF:
0.552
AC:
66480
Asia WGS
AF:
0.434
AC:
1508
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
12
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0075
T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.000010
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.26
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.099
Sift
Benign
0.31
T
Sift4G
Benign
0.22
T
Polyphen
0.94
P
Vest4
0.089
MPC
0.27
ClinPred
0.025
T
GERP RS
3.0
Varity_R
0.019
gMVP
0.10
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs530978; hg19: chr9-79324179; COSMIC: COSV65038633; API